Recent Updates — ACHC

Acadia Healthcare Company, Inc. announced that a U.S. District Court granted preliminary approval for the settlement of multiple stockholder derivative actions alleging breaches of fiduciary duty and securities violations by former directors and officers. Under the terms, Defendants’ Side A-DIC insurance carriers will pay $12,000,000 in cash to Acadia. The Company will also pay $4,750,000 in attorneys' fees and expenses to Plaintiffs’ Counsel. Additionally, Acadia agreed to implement corporate governance reforms for a period of at least four years. The settlement resolves claims related to insider trading allegations and other conduct associated with previously settled securities litigation. Acadia Healthcare Company, Inc. operates acute inpatient psychiatric facilities, specialty treatment centers, and outpatient behavioral healthcare services throughout the U.S. and Puerto Rico.

Acadia Healthcare Company, Inc. reported second quarter 2026 financial results on July 28, 2026. Total revenue was $865.8 million, flat year-over-year, while net income attributable to Acadia fell 64% to $10.9 million, or $0.12 per diluted share, compared to $30.1 million in the prior year. Adjusted EBITDA declined 26% to $149.2 million, impacted by a $28.6 million adjustment to professional and general liability reserves. The company added 240 licensed beds through new joint venture facilities in Florida and Iowa. Acadia updated its full-year 2026 guidance, raising the revenue range to $3.40–$3.45 billion and adjusted EBITDA to $590–$615 million. The company operates acute inpatient psychiatric facilities, specialty treatment centers, and residential treatment centers providing behavioral healthcare services across the United States and Puerto Rico.